世界のB型肝炎ウイルス(HBV)市場2026:インサイト・予測

QYResearchが発行した調査報告書(QYR20NV12166)
◆英語タイトル:Global Hepatitis B Vir (HBV) Market Size, Status and Forecast 2020-2026
◆商品コード:QYR20NV12166
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年11月(※2024年版があります。お問い合わせください。)
◆ページ数:93
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートはB型肝炎ウイルス(HBV)の世界市場について調査・分析した資料です。種類別(治療薬、ワクチン)の市場規模、用途別(病院、外来手術センター、診断センター)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別B型肝炎ウイルス(HBV)の競争状況、市場シェア
・世界のB型肝炎ウイルス(HBV)市場:種類別市場規模 2015年-2020年(治療薬、ワクチン)
・世界のB型肝炎ウイルス(HBV)市場:種類別市場規模予測 2021年-2026年(治療薬、ワクチン)
・世界のB型肝炎ウイルス(HBV)市場:用途別市場規模 2015年-2020年(病院、外来手術センター、診断センター)
・世界のB型肝炎ウイルス(HBV)市場:用途別市場規模予測 2021年-2026年(病院、外来手術センター、診断センター)
・北米のB型肝炎ウイルス(HBV)市場分析:米国、カナダ
・ヨーロッパのB型肝炎ウイルス(HBV)市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのB型肝炎ウイルス(HBV)市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のB型肝炎ウイルス(HBV)市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのB型肝炎ウイルス(HBV)市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Merck、Gilead Sciences、Novartis、GlaxoSmithKline、Hoffmann、La Roche、Bristol-Myers Squibb
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Over the recent years, the global Hepatitis B Treatment industry has been driven by the increasing number of patients diagnosed with Chronic Hepatitis B which results in severe complications, rising awareness about the consequences of viral infection, rigorous efforts to eliminate the viral infection, improving surveillance and diagnostic facilities, significant number of drugs in pipeline with better efficacy coupled with emerging vaccines with lower dosage and better effectiveness. Globally, the growth in Hepatitis B Treatment market is driven by backed by growing middle class population group demanding better drugs to improve lifestyle.
Among the type of treatment, therapeutics accounts for the major market share and anticipated to witness significant growth rate during the forecast period. Among the regions, Asia Pacific is predicted to advance at the highest rate, mainly driven by large population suffering with chronic Hepatitis B virus with unfulfilled need, improving access to healthcare, changing lifestyle and expanding middle class income group.

Market Analysis and Insights: Global Hepatitis B Vir (HBV) Market
The global Hepatitis B Vir (HBV) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Hepatitis B Vir (HBV) Scope and Market Size
Hepatitis B Vir (HBV) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hepatitis B Vir (HBV) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Merck
Gilead Sciences
Novartis
GlaxoSmithKline
Hoffmann
La Roche
Bristol-Myers Squibb

Market segment by Type, the product can be split into
Therapeutics
Vaccine
Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Hepatitis B Vir (HBV) Revenue
1.4 Market by Type
1.4.1 Global Hepatitis B Vir (HBV) Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Therapeutics
1.4.3 Vaccine
1.5 Market by Application
1.5.1 Global Hepatitis B Vir (HBV) Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Diagnostic Centers
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Hepatitis B Vir (HBV) Market Perspective (2015-2026)
2.2 Global Hepatitis B Vir (HBV) Growth Trends by Regions
2.2.1 Hepatitis B Vir (HBV) Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Hepatitis B Vir (HBV) Historic Market Share by Regions (2015-2020)
2.2.3 Hepatitis B Vir (HBV) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Hepatitis B Vir (HBV) Market Growth Strategy
2.3.6 Primary Interviews with Key Hepatitis B Vir (HBV) Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Hepatitis B Vir (HBV) Players by Market Size
3.1.1 Global Top Hepatitis B Vir (HBV) Players by Revenue (2015-2020)
3.1.2 Global Hepatitis B Vir (HBV) Revenue Market Share by Players (2015-2020)
3.1.3 Global Hepatitis B Vir (HBV) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Hepatitis B Vir (HBV) Market Concentration Ratio
3.2.1 Global Hepatitis B Vir (HBV) Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Hepatitis B Vir (HBV) Revenue in 2019
3.3 Hepatitis B Vir (HBV) Key Players Head office and Area Served
3.4 Key Players Hepatitis B Vir (HBV) Product Solution and Service
3.5 Date of Enter into Hepatitis B Vir (HBV) Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Hepatitis B Vir (HBV) Historic Market Size by Type (2015-2020)
4.2 Global Hepatitis B Vir (HBV) Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Hepatitis B Vir (HBV) Market Size by Application (2015-2020)
5.2 Global Hepatitis B Vir (HBV) Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Hepatitis B Vir (HBV) Market Size (2015-2020)
6.2 Hepatitis B Vir (HBV) Key Players in North America (2019-2020)
6.3 North America Hepatitis B Vir (HBV) Market Size by Type (2015-2020)
6.4 North America Hepatitis B Vir (HBV) Market Size by Application (2015-2020)

7 Europe
7.1 Europe Hepatitis B Vir (HBV) Market Size (2015-2020)
7.2 Hepatitis B Vir (HBV) Key Players in Europe (2019-2020)
7.3 Europe Hepatitis B Vir (HBV) Market Size by Type (2015-2020)
7.4 Europe Hepatitis B Vir (HBV) Market Size by Application (2015-2020)

8 China
8.1 China Hepatitis B Vir (HBV) Market Size (2015-2020)
8.2 Hepatitis B Vir (HBV) Key Players in China (2019-2020)
8.3 China Hepatitis B Vir (HBV) Market Size by Type (2015-2020)
8.4 China Hepatitis B Vir (HBV) Market Size by Application (2015-2020)

9 Japan
9.1 Japan Hepatitis B Vir (HBV) Market Size (2015-2020)
9.2 Hepatitis B Vir (HBV) Key Players in Japan (2019-2020)
9.3 Japan Hepatitis B Vir (HBV) Market Size by Type (2015-2020)
9.4 Japan Hepatitis B Vir (HBV) Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Hepatitis B Vir (HBV) Market Size (2015-2020)
10.2 Hepatitis B Vir (HBV) Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Hepatitis B Vir (HBV) Market Size by Type (2015-2020)
10.4 Southeast Asia Hepatitis B Vir (HBV) Market Size by Application (2015-2020)

11 India
11.1 India Hepatitis B Vir (HBV) Market Size (2015-2020)
11.2 Hepatitis B Vir (HBV) Key Players in India (2019-2020)
11.3 India Hepatitis B Vir (HBV) Market Size by Type (2015-2020)
11.4 India Hepatitis B Vir (HBV) Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Hepatitis B Vir (HBV) Market Size (2015-2020)
12.2 Hepatitis B Vir (HBV) Key Players in Central & South America (2019-2020)
12.3 Central & South America Hepatitis B Vir (HBV) Market Size by Type (2015-2020)
12.4 Central & South America Hepatitis B Vir (HBV) Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Merck
13.1.1 Merck Company Details
13.1.2 Merck Business Overview
13.1.3 Merck Hepatitis B Vir (HBV) Introduction
13.1.4 Merck Revenue in Hepatitis B Vir (HBV) Business (2015-2020))
13.1.5 Merck Recent Development
13.2 Gilead Sciences
13.2.1 Gilead Sciences Company Details
13.2.2 Gilead Sciences Business Overview
13.2.3 Gilead Sciences Hepatitis B Vir (HBV) Introduction
13.2.4 Gilead Sciences Revenue in Hepatitis B Vir (HBV) Business (2015-2020)
13.2.5 Gilead Sciences Recent Development
13.3 Novartis
13.3.1 Novartis Company Details
13.3.2 Novartis Business Overview
13.3.3 Novartis Hepatitis B Vir (HBV) Introduction
13.3.4 Novartis Revenue in Hepatitis B Vir (HBV) Business (2015-2020)
13.3.5 Novartis Recent Development
13.4 GlaxoSmithKline
13.4.1 GlaxoSmithKline Company Details
13.4.2 GlaxoSmithKline Business Overview
13.4.3 GlaxoSmithKline Hepatitis B Vir (HBV) Introduction
13.4.4 GlaxoSmithKline Revenue in Hepatitis B Vir (HBV) Business (2015-2020)
13.4.5 GlaxoSmithKline Recent Development
13.5 Hoffmann
13.5.1 Hoffmann Company Details
13.5.2 Hoffmann Business Overview
13.5.3 Hoffmann Hepatitis B Vir (HBV) Introduction
13.5.4 Hoffmann Revenue in Hepatitis B Vir (HBV) Business (2015-2020)
13.5.5 Hoffmann Recent Development
13.6 La Roche
13.6.1 La Roche Company Details
13.6.2 La Roche Business Overview
13.6.3 La Roche Hepatitis B Vir (HBV) Introduction
13.6.4 La Roche Revenue in Hepatitis B Vir (HBV) Business (2015-2020)
13.6.5 La Roche Recent Development
13.7 Bristol-Myers Squibb
13.7.1 Bristol-Myers Squibb Company Details
13.7.2 Bristol-Myers Squibb Business Overview
13.7.3 Bristol-Myers Squibb Hepatitis B Vir (HBV) Introduction
13.7.4 Bristol-Myers Squibb Revenue in Hepatitis B Vir (HBV) Business (2015-2020)
13.7.5 Bristol-Myers Squibb Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

...

【掲載企業】

Merck、Gilead Sciences、Novartis、GlaxoSmithKline、Hoffmann、La Roche、Bristol-Myers Squibb

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のB型肝炎ウイルス(HBV)市場2026:インサイト・予測(Global Hepatitis B Vir (HBV) Market Size, Status and Forecast 2020-2026)]についてメールでお問い合わせはこちらでお願いします。